FOLH1 and prostate carcinoma: In one study, 68Ga-PSMA-11 detected 88 prostate cancer lesions, including local recurrence, lymph node metastases, and lung, bone, and soft-tissue metastases, with an overall positive lesion detection rate of 71% [68].